The FDA has just announced the approval of a new prescription based treatment called Latisse for the treatment of hypotrichosis of the eyelashes. Hypotrichoiss is another name for having inadequate or not long enough eyelashes. Allergan, the manufacture of Latisse, … Continue reading →